Arunava Ghosh

Dr. Arunava Ghosh

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2018 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
AGArunava Ghosh
Arunava Ghosh
RCRaymond C. Coakley
Raymond C. Coakley
TMTeresa Mascenik
Teresa Mascenik
TRTemperance R. Rowell
Temperance R. Rowell
EDEric S. Davis
Eric S. Davis
RTRobert Tarran
Robert Tarran
Rationale: E-cigarettes vaporize propylene glycol/vegetable glycerin (PG/VG), nicotine, and flavorings. However, the long-term health effects of exposing lungs to vaped e-liquids are unknown. Objectives: To determine the effects of chronic vaping on pulmonary epithelia. Methods: We performed research bronchoscopies on healthy nonsmokers, cigarette smokers, and e-cigarette users (vapers) and obtained bronchial brush biopsies and lavage samples from these subjects for proteomic investigation. We further employed in vitro and murine exposure models to support our human findings. Measurements and Main Results: Visual inspection by bronchoscopy revealed that vaper airways appeared friable and erythematous. Epithelial cells from biopsy samples revealed approximately 300 proteins that were differentially expressed in smoker and vaper airways, with only 78 proteins being commonly altered in both groups and 113 uniquely altered in vapers. For example, CYP1B1 (cytochrome P450 family 1 subfamily B member 1), MUC5AC (mucin 5 AC), and MUC4 levels were increased in vapers. Aerosolized PG/VG alone significantly increased MUC5AC protein in human airway epithelial cultures and in murine nasal epithelia in vivo. We also found that e-liquids rapidly entered cells and that PG/VG reduced membrane fluidity and impaired protein diffusion. Conclusions: We conclude that chronic vaping exerts marked biological effects on the lung and that these effects may in part be mediated by the PG/VG base. These changes are likely not harmless and may have clinical implications for the development of chronic lung disease. Further studies will be required to determine the full extent of vaping on the lung.

12 June 2015 in Cellular and Molecular Life Sciences
Verified
Journal Article
Closed access
PDF file
AGArunava Ghosh
Arunava Ghosh
RBR. C. Boucher
R. C. Boucher
RTRobert Tarran
Robert Tarran

27 April 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
AGArunava Ghosh
Arunava Ghosh
SASabri H. Abdelwahab
Sabri H. Abdelwahab
SRSteven L. Reeber
Steven L. Reeber
BRBoris Reidel
Boris Reidel
AMAbigail J. Marklew
Abigail J. Marklew
RTRobert Tarran
Robert Tarran
Little cigars (LCs) are regulated differently than cigarettes, allowing them to be potentially targeted at youth/young adults. We exposed human bronchial epithelial cultures (HBECs) to air or whole tobacco smoke from cigarettes vs. LCs. Chronic smoke exposure increased the number of dead cells, lactate dehydrogenase release, and interleukin-8 (IL-8) secretion and decreased apical cilia, cystic fibrosis transmembrane conductance regulator (CFTR) protein levels, and transepithelial resistance. These adverse effects were significantly greater in LC-exposed HBECs than cigarette exposed cultures. LC-exposure also elicited unique gene expression changes and altered the proteomic profiles of airway apical secretions compared to cigarette-exposed HBECs. Gas chromatography-mass spectrometry (GC-MS) analysis indicated that LCs produced more chemicals than cigarettes, suggesting that the increased chemical load of LCs may be the cause of the greater toxicity. This is the first study of the biological effects of LCs on pulmonary epithelia and our observations strongly suggest that LCs pose a more severe danger to human health than cigarettes.

1 February 2012 in Toxicology
Verified
Journal Article
Closed access
AGArunava Ghosh
Arunava Ghosh
ACAparajita Choudhury
Aparajita Choudhury
ADArchita Das
Archita Das
NCNabendu S. Chatterjee
Nabendu S. Chatterjee
TDTanusree Das
Tanusree Das
ICIndu B. Chatterjee
Indu B. Chatterjee

9 October 2020 in Journal of Applied Toxicology
Verified
Journal Article
Closed access
PDF file
AGArunava Ghosh
Arunava Ghosh
OBOzge Beyazcicek
Ozge Beyazcicek
EDEric S. Davis
Eric S. Davis
Rob OnyenwokeRob Onyenwoke
Rob Onyenwoke
RTRobert Tarran
Robert Tarran

1 January 2016 in Toxicology Reports
Verified
Journal Article
Open access
AGArunava Ghosh
Arunava Ghosh
SBSantanu Banerjee
Santanu Banerjee
AMAmrita Mitra
Amrita Mitra
MMMonita Muralidharan
Monita Muralidharan
BRBappaditya Roy
Bappaditya Roy
ICIndu B. Chatterjee
Indu B. Chatterjee
Cigarette smoke (CS) is an important source of morbidity and early mortality worldwide. Besides causing various life-threatening diseases, CS is also known to cause hypoxia. Chronic hypoxia would induce early aging and premature death. Continuation of smoking during pregnancy is a known risk for the unborn child. Although carbon monoxide (CO) is considered to be a cause of hypoxia, the effect of other component(s) of CS on hypoxia is not known. Here we show by immunoblots and mass spectra analyses that in smoker's blood p-benzoquinone (p-BQ) derived from CS forms covalent adducts with cysteine 93 residues in both the β chains of hemoglobin (Hb) producing Hb-p-BQ adducts. UV-vis spectra and CD spectra analyses show that upon complexation with p-BQ the structure of Hb is altered. Compared to nonsmoker's Hb, the content of α-helix decreased significantly in smoker's Hb (p = 0.0224). p-BQ also induces aggregation of smoker's Hb as demonstrated by SDS-PAGE, dynamic light scattering and atomic force microscopy. Alteration of Hb structure in smoker's blood is accompanied by reduced oxygen binding capacity. Our results provide the first proof that p-BQ is a cause of hypoxia in smokers. We also show that although both p-BQ and CO are responsible for causing hypoxia in smokers, exposure to CO further affects the function over and above that produced by Hb-p-BQ adduct.